Positron Corporation
 | |
| Company type | Public |
|---|---|
| OTC Pink: POSC | |
| Industry | Healthcare |
| Founded | (1983) |
| Headquarters | , |
| Products | Nuclear medical PET imaging devices |
| Website | www |
Positron Corporation is an American nuclear medicine healthcare company specializing in cardiac Positron Emission Tomography (PET) imaging.[1][2] Positron is headquartered in Niagara Falls, New York in addition to its clinical and technical cardiovascular PET training facility.[3][4]
The company's products and services enable healthcare providers to diagnose cardiac disease and improve patient outcomes.[3][5] Positron Corporation is a public company and traded on the Financial Industry Regulatory Authority, Inc.'s OTC Bulletin Board under the ticker symbol POSC.[4][6]
History
[edit]Positron was founded in 1983 as a research and development company.[7][8]
Company development
[edit]After its founding in 1983, Positron debuted a new time-of-flight tomograph called the POSICAM.[9] Posicam used barium fluoride for the scintillation detector and was primarily used by researchers interested in cardiac imaging.[9] In 1985, the FDA approved the POSICAM system for marketing and the following year, Positron began commercial operations.[10] The FDA later gave approval to Positron to begin marketing its HZ PET imaging system in 1991.[10] Positron received patents for aspects of its HZ and HZL POSICAM systems in 1993 along with FDA approval to market HZL.[11]
In 2005, Positron entered into a joint venture contract with Neusoft Medical Systems Co., Inc. of Shenyang, China for a jointly owned company to pursue the manufacturing of PET imaging equipment called Neusoft Positron Medical Systems Co. Ltd.[12][11] The following year, Positron acquired a manufacturer/developer of nuclear imaging devices called IS2 Medical Systems, Inc. based in Ontario, Canada.[13] Positron acquired DoseShield Corporation, a developer and manufacturer of automated radiopharmaceutical technology/systems in 2008.[14] In 2009, Positron and its partner Neusoft Medical Systems received FDA approval to sell and distribute their Attrius PET system.[15][16]
Attrius
[edit]The Attrius is Positron's main cardiac PET system that the company provides in nuclear medicine that was launched in 2010.[12] The system uses software to monitor coronary artery overlay display and open architecture for new protocol development and customization and motion correction.[17][18] Other products include PosiRx, a system that simplifies and controls the procedures associated with the preparation and delivery of radiopharmaceuticals used in molecular imaging and PosiStar, Positron's customer care plan for Attrius.[4]
Awards
[edit]- Positron Corporation is the winner of the 2010 North American Molecular Imagine Systems New Product Innovation Award given by the research firm Frost & Sullivan.[4]
References
[edit]- ^ "Positron Corp". Morning Star. Retrieved 16 June 2014.
- ^ "Positron Corp. touts regulatory wins in U.S., U.K." Mass Device. 22 August 2012. Retrieved 16 June 2014.
- ^ a b "Positron Corp. (POSC) Positioned To Capitalize On Burgeoning PET Imaging Market". Seeking Alpha. 9 April 2013. Retrieved 16 June 2014.
- ^ a b c d Nadia Ibanez. "Positron Brings Innovation and Efficiency to Nuclear Medicine". Business Review USA. Archived from the original on 16 June 2014. Retrieved 16 June 2014.
- ^ Patrick G. Rooney (19 March 2012). "Positron Corporation". The Wall Street Transcript. Retrieved 16 June 2014.
- ^ Colorado Stark (24 March 2011). "Positron Corporation (OTC:POSC) Still Attracting Attention". Trader Planet. Retrieved 16 June 2014.
- ^ "Company". Retrieved 16 June 2014.
- ^ "Form 10-K". U.S. Securities and Exchange Commission. 2012. Retrieved 16 June 2014.
- ^ a b "The History PET Ronald Nutt, PhD" (PDF). ABT Molecular Imaging, Inc. Archived from the original (PDF) on 19 June 2014. Retrieved 16 June 2014.
- ^ a b "Form 10-KSB". U.S. Securities and Exchange Commission. 2006. Retrieved 16 June 2014.
- ^ a b "POSITRON CORP, Form 10KSB, Filing Date Apr 13, 2007". secdatabase.com. Retrieved May 15, 2018.
- ^ a b "Positron Corp - Initiating Coverage at Hold". Zacks. 9 September 2011. Retrieved 16 June 2014.
- ^ "Positron buys gamma camera firm IS2". Aunt Minnie. 6 June 2006. Retrieved 16 June 2014.
- ^ "Positron acquires Dose Shield, forms new subsidiary". Houston Business Journal. 12 June 2008. Retrieved 16 June 2014.
- ^ "Positron's Attrius Scanner Product Line Gets FDA Approval". FDA News. Retrieved 16 June 2014.
- ^ Dan Harvey (May 2012). "Cardiology Focus". Radiology Today Magazine. Retrieved 16 June 2014.
- ^ "Form 10-K". U.S. Securities and Exchange Commission. 2012. Retrieved 16 June 2014.
- ^ Lisa Fratt (24 March 2011). "Inside the Transition to Flow-Based Patient Care". Cardiovascular Business. Retrieved 16 June 2014.
